- Home
- TE vs SWKH Comparison
TE vs SWKH Comparison
Compare TE & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TE
- SWKH
- Stock Information
- Founded
- TE N/A
- SWKH 1996
- Country
- TE United States
- SWKH United States
- Employees
- TE N/A
- SWKH N/A
- Industry
- TE
- SWKH Diversified Financial Services
- Sector
- TE
- SWKH Finance
- Exchange
- TE NYSE
- SWKH Nasdaq
- Market Cap
- TE 191.8M
- SWKH 179.1M
- IPO Year
- TE N/A
- SWKH 1999
- Fundamental
- Price
- TE $1.24
- SWKH $14.92
- Analyst Decision
- TE
- SWKH Strong Buy
- Analyst Count
- TE 0
- SWKH 1
- Target Price
- TE N/A
- SWKH $18.00
- AVG Volume (30 Days)
- TE 2.4M
- SWKH 17.5K
- Earning Date
- TE 08-11-2025
- SWKH 08-14-2025
- Dividend Yield
- TE N/A
- SWKH N/A
- EPS Growth
- TE N/A
- SWKH 51.50
- EPS
- TE N/A
- SWKH 1.41
- Revenue
- TE $67,589,000.00
- SWKH $34,906,000.00
- Revenue This Year
- TE $34,332.36
- SWKH $52.93
- Revenue Next Year
- TE $60.81
- SWKH N/A
- P/E Ratio
- TE N/A
- SWKH $10.65
- Revenue Growth
- TE N/A
- SWKH 18.02
- 52 Week Low
- TE $0.91
- SWKH $12.00
- 52 Week High
- TE $3.36
- SWKH $16.24
- Technical
- Relative Strength Index (RSI)
- TE N/A
- SWKH 66.21
- Support Level
- TE N/A
- SWKH $14.46
- Resistance Level
- TE N/A
- SWKH $15.28
- Average True Range (ATR)
- TE 0.00
- SWKH 0.33
- MACD
- TE 0.00
- SWKH 0.07
- Stochastic Oscillator
- TE 0.00
- SWKH 95.58
About TE T1 ENERGY INC
T1 Energy Inc is an energy solutions producer of clean battery solutions. The company acts as a solar manufacturing company in the USA with complementary solar and battery storage.
About SWKH SWK Holdings Corporation
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.